These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16027259)

  • 1. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Jones JE; Beppu H; Keaney JF; Loscalzo J; Zhang YY
    Circulation; 2005 Jul; 112(4):553-62. PubMed ID: 16027259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
    Mushaben EM; Hershey GK; Pauciulo MW; Nichols WC; Le Cras TD
    PLoS One; 2012; 7(3):e32468. PubMed ID: 22427841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.
    West J; Harral J; Lane K; Deng Y; Ickes B; Crona D; Albu S; Stewart D; Fagan K
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L744-55. PubMed ID: 18723761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
    Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
    Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene.
    Park SH; Chen WC; Hoffman C; Marsh LM; West J; Grunig G
    PLoS One; 2013; 8(1):e55180. PubMed ID: 23383100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic and molecular consequences of endothelial Bmpr2 mutation.
    Majka S; Hagen M; Blackwell T; Harral J; Johnson JA; Gendron R; Paradis H; Crona D; Loyd JE; Nozik-Grayck E; Stenmark KR; West J
    Respir Res; 2011 Jun; 12(1):84. PubMed ID: 21696628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP signaling controls PASMC KV channel expression in vitro and in vivo.
    Young KA; Ivester C; West J; Carr M; Rodman DM
    Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L841-8. PubMed ID: 16339782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.
    Talati M; West J; Blackwell TR; Loyd JE; Meyrick B
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L363-73. PubMed ID: 20562228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.
    Talati MH; Brittain EL; Fessel JP; Penner N; Atkinson J; Funke M; Grueter C; Jerome WG; Freeman M; Newman JH; West J; Hemnes AR
    Am J Respir Crit Care Med; 2016 Sep; 194(6):719-28. PubMed ID: 27077479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
    Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
    Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
    West JD; Carrier EJ; Bloodworth NC; Schroer AK; Chen P; Ryzhova LM; Gladson S; Shay S; Hutcheson JD; Merryman WD
    PLoS One; 2016; 11(2):e0148657. PubMed ID: 26863209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature.
    Frank DB; Lowery J; Anderson L; Brink M; Reese J; de Caestecker M
    Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L98-109. PubMed ID: 18024717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
    Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
    J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.